466-01-005 ISMRM Abstract

Prediction of Rectal Cancer Microsatellite Instability by Integrating MR Radiomics, Habitat Analysis, and Genomics

Primary: Body - Digestive

Secondary: Analysis Methods - Radiomics

466-01-005 · Rectal Cancer · Tuesday, 12 May, 8:20 AM–9:15 AM · Digital Posters Row G

Accepted

lixin LI¹, yuping Bai ¹, Duo Yang²

¹Department of Magnetic Resonance, Lanzhou, China

²The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China

Presenting Author: yuping Bai

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. [1]Jenkins MA, Hayashi S, O'Shea AM, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 2007;133(1):48-56. doi:10.1053/j.gastro.2007.04.044. PMID: 17631132. [doi] [pmid]

2. [2]Jo WS, Carethers JM. Chemotherapeutic implications in microsatellite unstable colorectal cancer. Cancer Biomark. 2006;2(1-2):51-60. doi:10.3233/cbm-2006-21-206. PMID: 17192060. [doi] [pmid]

3. [3]Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010;7(3):153-162. doi:10.1038/nrclinonc.2009.237. PMID: 20142816. [doi] [pmid]

4. [4]He W, Huang W, Zhang L, Wu X, Zhang S, Zhang B. Radiogenomics: bridging the gap between imaging and genomics for precision oncology. MedComm (2020). 2024;5(9):e722. doi:10.1002/mco2.722. PMID: 38946892. [doi] [pmid]

5. [5]Wu J, Cao K, Jin S, et al. Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-Free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy. Radiology. 2018;288(1):26-35. doi:10.1148/radiol.2018172462. PMID: 29584598. [doi] [pmid]

6. [6]Le DT, Durham JN, Smith KN, et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med. 2015;372(26):2509-2520. doi:10.1056/NEJMoa1500596. PMID: 26028255. [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/466-01-005